Magenta is harnessing stem cell biology to make transplants safer and more effective for patients with immune and blood-based diseases
Magenta Therapeutics Inc.
[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”MGTA” api=”yf” style=”font-size: 15px”]
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.magentatx.com
Founded2015
Disease Focus
Development Stage
STOCK CODENASDAQ: MGTA
Address50 Hampshire St, MA 02139CambridgeUnited States
50 Hampshire St, MA 02139
Cambridge
United States
Contact Number+1 857 242 0170
+1 857 242 0170
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/magenta-therapeutics
” connections=”true” suffix=””]